<DOC>
	<DOCNO>NCT01705626</DOCNO>
	<brief_summary>The purpose study determine prevalence patient polyneuropathy undetermined etiology base normal result laboratory data ( CRP , glucose , electrolytes , urea , transaminase , TSH , immunoglobulins , vitamin B12 , RF , ANA , antibodies Lyme borrelia ) anamnesis carcinoma , continuous alcohol consumption ; light-chain-amyloidosis ; anamnesis heavy metal exposure .</brief_summary>
	<brief_title>Screening Transthyretin-Related Familial Amyloidotic Small Fiber Polyneuropathy</brief_title>
	<detailed_description>Neuropathies generalise disorder peripheral nervous system , due derange function peripheral motor , sensory autonomic neuron , fibre myelin sheath . Dysfunction unmyelinated C myelinated Aδ fibre cause symptom like insensitivity hypersensitivity heat and/or cold neuropathic pain . These fibre slow conduction velocity , carry temperature feel pain sensation nociceptors thermoreceptor respectively . An isolated disturbance fibre lead usually diagnosis small fibre neuropathy ( SFN ) . The pathogenesis SFN may inflammatory , autoimmune , metabolic , toxic hereditary nature . Careful clinical electrodiagnostic assessment , attention pattern involvement type nerve fiber affect , narrow differential diagnosis help focus laboratory evaluation . Beside frequent genetic etiology PNP ( pmp22 , MFN2 ) one cause genetic polyneuropathy may hereditary amyloidosis . These described endemic Sweden , Portugal Japan . The common form hereditary familial amyloidotic neuropathy ( FAP ) Transthyretin-related FAP , however two amyloidogenic protein describe : Apolipoprotein A-I Gelsolin ( Ando et al. , 2005 ; Adams et al. , 2010 ) . This study focus TTR-FAP ( OMIM : # 105210 , OMIM : *176300 ) , whose prevalence shall determine cohort 500 patient polyneuropathy unknown etiology . The TTR-FAP autosomal dominant disease , exact prevalence unknown estimate around 1:100,000 1:1,000,000 normal population ( Orphanet , ORPHA 85447 ) . While diagnosis amyloidotic neuropathy conduct histologically , molecular genetic approach necessary diagnose TTR-FAP . Even though 100 point mutation know cause disease , common amino acid change V30M . The mutation TTR gene cause destabilization physiologically tetrameric protein . Usually transthyretin consist four identical monomeric subunit bind thyroxin circulate blood plasma . The monomeric subunit exhibit pronounce β-sheet structure lead accumulation unsoluble β-fibrils destabilise TTR-FAP .</detailed_description>
	<mesh_term>Polyneuropathies</mesh_term>
	<mesh_term>Amyloidosis</mesh_term>
	<mesh_term>Metabolic Diseases</mesh_term>
	<mesh_term>Amyloid Neuropathies</mesh_term>
	<mesh_term>Amyloidosis , Familial</mesh_term>
	<criteria>Informed consent obtain patient study related procedure Patients age old 18 year Patients small fiber polyneuropathy undetermined etiology base : normal result laboratory data ( CRP , glucose , electrolytes , urea , transaminase , TSH , immunoglobulins , vitamin B12 , RF , ANA , antibodies Lyme borrelia ) No anamnesis carcinoma No continuous alcohol consumption No lightchainamyloidosis No anamnesis heavy metal exposure Progressive idiopathic small fiber polyneuropathy No Informed Consent patient study related procedure Patients young 18 year The etiology small fiber polyneuropathy already know base : significant pathological result follow laboratory data ( CRP , glucose , electrolytes , urea , transaminase , TSH , immunoglobulins , vitamin B12 , RF , ANA , antibodies Lyme borrelia ) Positive anamnesis carcinoma Continuous alcohol consumption Lightchainamyloidosis Anamnesis heavy metal exposure No progression idiopathic small fiber polyneuropathy within last two year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Peripheral Nervous System Diseases</keyword>
	<keyword>Neuromuscular Diseases</keyword>
	<keyword>Nervous System Diseases</keyword>
	<keyword>Metabolism , Inborn Errors</keyword>
	<keyword>Genetic Diseases , Inborn</keyword>
</DOC>